These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12053927)

  • 21. Fusidic acid in dermatology: an updated review.
    Schöfer H; Simonsen L
    Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
    Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
    Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
    Rørtveit S; Skutlaberg DH; Langeland N; Rortveit G
    Scand J Infect Dis; 2014 Dec; 46(12):832-7. PubMed ID: 25229166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study.
    Osterlund A; Kahlmeter G; Haeggman S; Olsson-Liljequist B;
    Scand J Infect Dis; 2006; 38(5):334-4. PubMed ID: 16724423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of Fucidin Ointment and Cicatrin Cream in the treatment of impetigo.
    Cassels-Brown G
    Br J Clin Pract; 1981 Apr; 35(4):153-5. PubMed ID: 7028065
    [No Abstract]   [Full Text] [Related]  

  • 26. [Managing children skin and soft tissue infections].
    Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusidic acid resistance in Staphylococcus aureus.
    Dobie D; Gray J
    Arch Dis Child; 2004 Jan; 89(1):74-7. PubMed ID: 14709515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 29. Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.
    Rørtveit S; Rortveit G
    Br J Dermatol; 2007 Jul; 157(1):100-5. PubMed ID: 17553056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
    Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
    Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical inquiry: what is the best treatment for impetigo ?
    Shim J; Lanier J; Qui MK
    J Fam Pract; 2014 Jun; 63(6):333-5. PubMed ID: 25061625
    [No Abstract]   [Full Text] [Related]  

  • 33. Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
    Johnston C
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):797-8. PubMed ID: 1907980
    [No Abstract]   [Full Text] [Related]  

  • 34. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
    Alreshidi MA; Mariana NS
    Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461
    [No Abstract]   [Full Text] [Related]  

  • 35. A blistering child: a toddler with large bullae.
    Mohme S; Goebeler M; Hamm H
    Eur J Dermatol; 2021 Dec; 31(6):853-855. PubMed ID: 35107079
    [No Abstract]   [Full Text] [Related]  

  • 36. [Deficient documentation in the guidelines for antibiotics use].
    Andresen LK
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):540; author reply 540-1. PubMed ID: 19282894
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010.
    Shallcross LJ; Petersen I; Rosenthal J; Johnson AM; Freemantle N; Hayward AC
    Emerg Infect Dis; 2013 Oct; 19(10):1646-8. PubMed ID: 24047615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusidic acid: new opportunities with an old antibiotic.
    Anderson JD
    Can Med Assoc J; 1980 Apr; 122(7):765-9. PubMed ID: 6988070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].
    Peeters KA; Mascini EM; Blok HE; Sanders CJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2100-1. PubMed ID: 12448968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of Staphylococcus aureus to fusidic acid.
    Peeters KA; Mascini EM; Sanders CJ
    Int J Dermatol; 2004 Mar; 43(3):235-6. PubMed ID: 15009402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.